LifeSplice is a biotechnology company developing products for the treatment of severe neurological and non-neurological diseases with critical unmet needs. The firm's proprietary drug discovery technology offers partners a valuable mechanism rapidly to identify and initiate preclinical product development across a broad range of therapeutic areas including cancer, infectious diseases, and rare genetic disorders.
